Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TOR1AIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RPL10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
DIS3L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARPC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDUFAF7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEPN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDRG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR3658 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TUBB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORD18C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
FKBP10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRIN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100132731 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GOLGA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on